US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

29.07

0.0000

Volume:17

Turnover:493.61

Market Cap:1.02M

PE:- -

High:29.07

Open:29.07

Low:29.07

Close:29.07

52wk High:29.88

52wk Low:24.32

Shares:35.00K

Float Shares:35.00K

Volume Ratio:0.07

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Health Q2 EPS $(0.37) Misses Estimate, Sales $753.214M Beat $699.889M Estimate

Benzinga Earnings

Hims & Hers Health Shares Rise in Extended Trade Following Results, Last up 3% at $33

THOMSON REUTERS

Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million

Hims & Hers Health Q2 EPS USD -0.37

THOMSON REUTERS

Hims & Hers Health, Inc. Q3 REV View $793.1 Mln

THOMSON REUTERS

Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda

THOMSON REUTERS

Hims & Hers Health: Expect Our Domestic Business to Continue Accelerating Through the Second Half of the Year

THOMSON REUTERS

Enanta FY26 Q3 Net Loss Widens to $19.5 Million; Revenue Falls to $14.4 Million

U.S. Earnings Preview: After Market Close Aug. 10

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

Global Drugmakers Invest Billions to Boost US Presence

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)

Analysts Offer Insights on Consumer Goods Companies: Kenvue, Inc. (KVUE) and Turning Point Brands (TPB)

Apogee Net Loss Widens to $85.85 Million in Q2 FY26; R&D Expenses Rise to $67.3 Million

Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings

Did Align’s Expanded 2026 Buyback and Board Refresh Just Shift Align Technology's (ALGN) Investment Narrative?

Simply Wall St.

Hims & Hers Q2 Earnings Preview: Options Traders Brace for a 14.5% Move in HIMS Stock

Polymarket Odds: Will RKLB, HIMS, QUBT Beat Earnings on Monday?

AbbVie Targets Obesity Market With New Phase 2 ABBV-295 Trial

Spectrum Brands Q3 Sales Beat on Home, Garden Segment Growth

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/GLAM/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":29.073,"timestamp":1787670485278,"preClose":29.073,"halted":0,"volume":17,"delay":0,"changeRate":0,"floatShares":35000,"shares":35000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"08-25 13:02:48 EDT","open":29.073,"high":29.073,"low":29.073,"amount":493.61366599999997,"amplitude":0,"askPrice":29.05,"askSize":1400,"bidPrice":29,"bidSize":1400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":29.073,"nav":28.91,"aum":1011850,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":29,"preClose":29.073,"latestTime":"17:51 EDT","volume":5,"amount":145.852,"timestamp":1787608315034,"change":-0.073,"changeRate":-0.002511,"amplitude":0},"volumeRatio":0.072896,"impliedVol":0.2298,"impliedVolPercentile":0.0882},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":35000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.072896,"shares":35000,"dividePrice":0,"high":29.073,"amplitude":0,"preClose":29.073,"low":29.073,"week52Low":24.3178,"pbRate":"--","week52High":29.88,"institutionHeld":0,"latestPrice":29.073,"eps":0,"divideRate":0,"volume":17,"delay":0,"ttmEps":0,"open":29.073,"prevYearClose":25.82,"prevWeekClose":28.9156,"prevMonthClose":27.9767,"prevQuarterClose":27.6454,"fiveDayClose":27.9474,"twentyDayClose":28.7157,"sixtyDayClose":24.7324},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658959874","title":"Hims & Hers Health Q2 EPS $(0.37) Misses Estimate, Sales $753.214M Beat $699.889M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959874","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959874?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392452,"startTime":"0","endTime":"0","summary":"Hims &amp; Hers Health (NYSE:HIMS) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.03) by 1133.33 percent. This is a 317.65 percent decrease over earnings of $0.17 per","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61091412/hims-hers-health-q2-eps-0-37-misses-0-03-estimate-sales-753-214m-beat-699-889m-estimate","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Health Q2 EPS $(0.37) Misses $(0.03) Estimate, Sales $753.214M Beat $699.889M Estimat...","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HEAL","GLAM","HIMZ","THNR","HIYY","HIMY","HMYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2658598159","title":"Hims & Hers Health Shares Rise in Extended Trade Following Results, Last up 3% at $33","url":"https://stock-news.laohu8.com/highlight/detail?id=2658598159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658598159?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392428,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL6N4470Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","HEAL","BK4196","HIMY","HIYY","HIMZ","THNR","HIMS","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959895","title":"Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959895","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959895?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:06","pubTimestamp":1786392361,"startTime":"0","endTime":"0","summary":"BRIEF-Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 MillionAug 10  - Hims & Hers Health Q2 net income USD -86.3 million.outlook FY revenue USD 3,100-3,300 million vs. IBES estimate USD 2,928 millionoutlook FY adjusted EBITDA USD 275-325 million vs. IBES estimate USD 296.2 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","HIMZ","GLAM","HIMY","HIMS","HEAL","HMYY","BK4196","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959814","title":"Hims & Hers Health Q2 EPS USD -0.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959814?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","GLAM","HIMZ","BK4196","HEAL","HMYY","THNR","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959546","title":"Hims & Hers Health, Inc. Q3 REV View $793.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959546?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","GLAM","HIMZ","BK4196","HEAL","HMYY","THNR","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956027","title":"Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956027?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMY","HIMS","BK4196","HIMZ","HIYY","THNR","GLAM","HEAL","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658051956","title":"Hims & Hers Health: Expect Our Domestic Business to Continue Accelerating Through the Second Half of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2658051956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658051956?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMZ","THNR","HEAL","HMYY","GLAM","HIMS","HIYY","BK4196","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956419","title":"Enanta FY26 Q3 Net Loss Widens to $19.5 Million; Revenue Falls to $14.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956419","media":"Reuters","labels":["policyRegulatory","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956419?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:02","pubTimestamp":1786392129,"startTime":"0","endTime":"0","summary":"Enanta FY26 Q3 net loss widens to $19.5 million; revenue falls to $14.4 millionEnanta posted fiscal Q3 revenue of USD 14.4 million, down 21.6% year over year, on lower AbbVie MAVYRET/MAVIRET net sales","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL47q05R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JDOC","IE00BLSP4239.USD","AGNG","ABBV","GLAM","IE00BLSP4452.SGD","RXL","BK4139","XLV","FTXH","PJP","LU1839511570.USD","LU1670628061.USD","LU0726765562.USD","LU2129689514.USD","LU0689472784.USD","VHT","LU1989771016.USD","IE0004445239.USD","LU0124676726.USD","IE00B19Z3581.USD","FHLC","LU0211328371.USD","LU1929549753.HKD","LU1670627923.USD","LU1551013342.USD","LU0128525929.USD","LU1923622614.USD","LU2237443549.SGD","LU1732800096.USD","LU1496350171.SGD","LU1585245621.USD","LU0256863811.USD","TRUH","LU1496350502.SGD","LU2237443895.HKD","IE00B2B36J28.USD","LU0868494617.USD","ENTA","LU1989772840.SGD","LU1162221912.USD","IXJ","IYH","IE00BN8TJ469.HKD","LU0234570918.USD","LU0256863902.USD","LU0289739699.SGD","LU0058720904.USD","PPH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956339","title":"U.S. Earnings Preview: After Market Close Aug. 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956339","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956339?lang=en_us&edition=fundamental","pubTime":"2026-08-11 03:30","pubTimestamp":1786390200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results after the marke","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APEI","LU0842063009.USD","GLAM","GQRE","BK4137","BK4130","RNTY","LU2298064838.USD","BBRE","LU1499592464.USD","BZH","BK4161","BK4516","RSPR","BK4139","IYR","THNR","DFGR","BK4080","LU0187121727.USD","HIMY","HLIO","BK4505","LU2360107325.USD","BK4129","JRE","UPWK","ICF","DPRE","LU0689626769.HKD","FRI","ACM","TRUR","DFAR","RWR","BK4187","AVRE","IE00B66KJ199.SGD","RWO","IQRA","URE","ACHR","FREL","BBIO","BK4088","BK4603","USRT","BK4166","ACVA","IE00B19Z4B17.USD","ERET","LU1861214812.USD","LU2238339852.HKD","LU0124676726.USD","LU2308191902.HKD","LU2190626999.HKD","BK4225","BK4585","VNQ","BK4185","BKD","SCHH","REET","XLRE","BK4204","BK4588","ARCX","BK4213","REIT","VGSR","BK4231","IE0031619046.USD","HIMS","NHI","HMYY","CRED","HPK","BK4203","LU2244417387.USD","HIYY","LU1861219969.SGD","IE00B7SZL793.SGD","HEAL","SPG","HIMZ","OPFI","LU1939255532.USD","RITA","BK4196","IYRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658713934","title":"Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2658713934","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658713934?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:47","pubTimestamp":1786369636,"startTime":"0","endTime":"0","summary":"• Vertex reported positive Phase 3 data for its non-opioid pain treatment candidate.\n• The company raised its full-year revenue guidance following successful international product launches.\n• Analysts maintain a Buy rating with an average price target of $557.64.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262092805-market-movers-vrtx-20260810","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","IE000WAW04H5.SGD","IYH","LU1023059063.AUD","IBB","IE00BSNM7G36.USD","LU0057025933.USD","LU0114720955.EUR","LU0868494708.USD","GLAM","LU0511384066.AUD","IE00BBT3K403.USD","IDNA","LU0289739343.SGD","BIB","AGNG","IE0004445239.USD","ISBC","CF","LU1839511570.USD","IBBQ","XLV","BBH","LU2433249047.HKD","IXJ","VERX","LU1585245621.USD","LU1559883803.SGD","TBXU","ABBV","PJP","BK4139","VEGI","IE000F7OJYX1.SGD","LU0098860793.USD","GNMX","PBE","LU0795875169.SGD","PPH","VHT","VRTX","LU0170899867.USD","RXL","JDOC","FTXH","AZNH","FHLC","LU1934455277.USD","TRUH","AZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931607","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931607?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:16","pubTimestamp":1786367800,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 10 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1228905037.USD","LU2125154778.USD","LU2462157665.USD","LU0353189680.USD","IE0009355771.USD","LU2468319806.SGD","LU0889566641.SGD","LU1037948897.HKD","LU2242646821.SGD","GSK.UK","LU0170899867.USD","LU1732799900.SGD","LU1162221912.USD","LU2168563687.JPY","LU0823416689.USD","SGXZ99366536.SGD","BK4504","IE00B775H168.HKD","LU2028103732.USD","IE000SO60NU8.SGD","LU0683600562.USD","JNJ","LLYX","LU0267386448.USD","IE00BVYPNV92.GBP","IE00BK4W5L77.USD","LU2023250504.SGD","LU2213496289.HKD","IE00B1XK9C88.USD","LU1868836757.USD","LU2023250843.SGD","LU0306806265.USD","LU2063271972.USD","LU2746668461.USD","HRTS","LU2491050071.SGD","IE00BWXC8680.SGD","LU0158827948.USD","LLII","LU1066053197.SGD","SG9999014542.SGD","LU2602419157.SGD","TMED","LU1548497426.USD","LU2505996681.GBP","LU0289739699.SGD","LU1670710661.SGD","SG9999011175.SGD","LU0426412945.USD","LU2237443549.SGD","SG9999014914.USD","LU0882574139.USD","LU1061106388.HKD","LU1929549753.HKD","SG9999015952.SGD","LU0203202063.USD","IE0002141913.USD","BK4550","BK4533","LU2237443622.USD","IE00BKPKM429.USD","LU0069063385.USD","LU2106854487.HKD","LU0128525929.USD","SG9999001176.USD","TRUH","LU0820562030.AUD","BIB","WDNA","LU0133085943.USD","LU2237438978.USD","LU0198837287.USD","LU1043141396.HKD","LU1127390331.HKD","LU2750360997.AUD","LU0792757196.USD","LU1093756325.SGD","LU1670711123.USD","LU1506573853.SGD","LU1934455277.USD","PAWZ","IE000F7OJYX1.SGD","LU0471298694.HKD","LU1291159041.SGD","LU2487616109.SGD","LU2361044949.HKD","LU1074936037.SGD","LU0354030511.USD","IE00B19Z9Z06.USD","LU1228905540.USD","SG9999014567.USD","LU0820561818.USD","LU0964807845.USD","LU0097036916.USD","BBH","LU2237443465.HKD","LU0130102774.USD","LU2129689514.USD","LU0109391861.USD","LU0787776722.HKD","BK4583","BK4559","LU1032955483.USD","LU1670628061.USD","LU1989772923.USD","BMED","LU2361045086.USD","IE00BJT1NW94.SGD","LU1551013425.SGD","LU0029864427.USD","BK4578","IE00BJJMRY28.SGD","LU1043141123.HKD","LU1232071149.USD","BK4581","IE0004445239.USD","LU0234570918.USD","BK4592","LU1883839398.USD","IE00BJJMRZ35.SGD","LU0949170772.SGD","IE00BLSP4239.USD","LU2089283258.USD","LU0098860793.USD","SG9999001176.SGD","CURE","LU0237698245.USD","LU1035775433.USD","IE000WAW04H5.SGD","LU0158827781.USD","LU1267930813.SGD","XLV","IHE","LU0094547139.USD","LU1989772840.SGD","LU2347655073.USD","LU0057025933.USD","GB00BDT5M118.USD","IBB","IE00BGHQF631.EUR","LU1037948541.HKD","IE00B3PB1722.GBP","LU1035773651.USD","LU2324357040.USD","LU0994945656.USD","LU2023251221.USD","PBE","LU1935042991.SGD","IE00B3T34201.USD","LU1267930730.SGD","LU1623119135.USD","IE00BBT3K403.USD","LU0310800379.SGD","LU2756315318.SGD","LU0726765562.USD","LU1778281490.HKD","LU1718418525.SGD","LU0985481810.HKD","LU1280957306.USD","LU0208291251.USD","LU0965509101.SGD","BK4566","LU2756315664.SGD","AMGN","IE000MB6IJN5.SGD","IE00BFSS7M15.SGD","LU0320765059.SGD","IE00BSNM7G36.USD","LU0985320562.USD","LU2347655156.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","SG9999001440.SGD","BK4588","BK4532","BK4568","LU0795875169.SGD","LU2087625088.SGD","LU1923622614.USD","LU0306807586.USD","LU0965509010.AUD","LU0211327993.USD","LU1496350502.SGD","CANC","LU0345769128.USD","LU1983299246.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","MEDX","IE00BDGV0183.EUR","LU1003077747.HKD","LU1496350171.SGD","IE00B4JS1V06.HKD","SG9999013999.USD","BK4534","GLAM","LU0385154629.USD","LU2211815571.USD","LU1066051811.HKD","LU0225771236.USD","LU0426417589.USD","LU0203201768.USD","LU2552382132.HKD","LU0965509283.SGD","TBXU","IXJ","LU0648001328.SGD","LU1093756168.USD","LU0321505868.SGD","LU1670627923.USD","LU0265550946.USD","LU1571399168.USD","IE00B7SZLL34.SGD","LU1934455863.HKD","ILDR","BK7067","LU0072461881.USD","LU0889565916.HKD","LU0466842654.USD","LU1267930573.SGD","BK4007","LU1814569148.SGD","PFE","IE00BK4W5M84.HKD","SGXZ81514606.USD","LU2456880835.USD","LU1934455194.USD","JDOC","IE0004445015.USD","LU1914381329.SGD","LU0124676726.USD","LU0823434740.USD","LU1059921491.USD","LU1121112475.USD","IE000BZT7R73.USD","IE00BJLML261.HKD","LU2236285917.USD","LU0162691827.USD","LU0210528500.USD","LU0316494557.USD","LU1712237335.SGD","LU0096364046.USD","LU2242652126.USD","LU1988902786.USD","LU0238689110.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU2125154935.USD","SG9999018865.SGD","LU1941712348.USD","PPH","LU2237443895.HKD","OZEM","IE00B4R5TH58.HKD","LU0689626769.HKD","LU1979441026.SGD","LU1894683348.USD","LU2271345857.HKD","SG9999014575.USD","LU0395794307.EUR","LU0070302665.USD","LU2357627491.SGD","SG9999002232.USD","LU0456855351.SGD","LU2471134952.CNY","LU2357305700.SGD","LU2087621335.USD","LU2265009873.SGD","FHLC","BK7501","GDOC","LU2264538146.SGD","IE0000B7K699.USD","LU2168564495.EUR","LU1894683264.USD","LU1069347547.HKD","PJP","CSL.AU","LU1670711040.USD","LU0553294199.USD","LU1868836914.USD","LU2433249047.HKD","LU0289739343.SGD","LU2168564222.USD","LU0320765489.SGD","LU0006306889.USD","LU1941712264.USD","IE00BZ1G4Q59.USD","LU1829250122.USD","LU0672654240.SGD","LU1917777945.USD","LU0965508806.USD","LU2491050154.USD","AZN","LU1145028129.USD","LU0472753341.HKD","LU1720051108.HKD","LU2461242641.AUD","LU0545039389.USD","LU0786609619.USD","LLY","LU0256863902.USD","SG9999014898.SGD","BK4139","LU0203347892.USD","04332","IE0005OL40V9.USD","IE00B7KXQ091.USD","LU0061475181.USD","LU0861579265.USD","LU0345770993.USD","LU2237443978.SGD","SG9999017495.SGD","BK4516","IBBQ","IE000M9KFDE8.USD","LU1057294990.SGD","LU2403377893.USD","VHT","LU2089284900.SGD","LU2471134879.HKD","LU2430703095.HKD","LU1323610961.USD","LU0320765646.SGD","SG9999015358.SGD","LU2361044865.SGD","GSK","LU2430703178.SGD","LU1066051225.USD","LU0640476718.USD","LU0079474960.USD","THNR","LU1720051017.SGD","LU1699723380.USD","IE00BN29S564.USD","LU1868837300.USD","ABBV","LU0130517989.USD","LU1804176565.USD","LU0321505439.SGD","SGXZ31699556.SGD","IE0002270589.USD","RXL","LU2168564149.EUR","LLYZ","LU2750360641.GBP","IE00BVYPNW00.USD","LU2896262040.SGD","LU0417517546.SGD","LU2125909247.SGD","BK7508","LU1267930490.SGD","IE00BFSS8Q28.SGD","LU1868836591.USD","IYH","LU0942090050.USD","LU1116320737.USD","LU1116320901.HKD","BMY","IE00BFXG1179.USD","LU0234572021.USD","LU1196500208.SGD","LU0174119429.USD","LU2129689605.HKD","LU0882574055.USD","LU1674673428.USD","LU2111349929.HKD","LU2360032135.SGD","MEDI","LU2746668974.SGD","MRK","GSKH","LU2552382215.SGD","LU0738911758.USD","LU2430703251.USD","LU1221951129.SGD","IE00B2B36J28.USD","BIIB","BK4599","AZNH","LU2471134523.USD","LU1732800096.USD","LU0868494708.USD","LU0211331839.USD","LU0345770308.USD","SG9999014880.SGD","FTXH","MHIP","LU2596442595.SGD","LU0210536198.USD","IE00BN8TJ469.HKD","LU1839511570.USD","LU1430594728.SGD","LU1261432733.SGD","LU1244550577.SGD","LU1674673691.USD","LU2491049909.HKD","LU0310799852.SGD","LU1066051498.USD","LU0353189763.USD","LU2592432038.USD","LU2108987350.USD","LU1366192091.USD","AGNG","LU0545562505.USD","SG9999014906.USD","LU2237443382.USD","LU0477156953.USD","LU0943347566.SGD","LU0122379950.USD","LU0820561909.HKD","LU2125909593.SGD","LU1670710588.SGD","IE00B19Z9P08.USD","IE00B1BXHZ80.USD","LU0823434583.USD","LU1064131342.USD","LU1629891620.HKD","GILD","SG9999015945.SGD","LU2112291526.USD","ELIL","LU0795875086.SGD","LU0511384066.AUD","LU1244550221.USD","LU2023250330.USD","LU0070217475.USD","LU0708995401.HKD","IE00BKVL7J92.USD","LU1023059063.AUD","LU0289961442.SGD","LU1551013342.USD","LU1244550494.USD","LU0106261372.USD","LU1201861249.SGD","LU0203345920.USD","IE00BJJMRX11.SGD","ELIS","LU0912757837.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU0471298777.SGD","LU2462591350.SGD","LU0320765992.SGD","LU0109394709.USD","SG9999014559.SGD","LU1032466523.USD","LU0708994859.HKD","LU0859254822.USD","SGXZ80539844.SGD","SG9999015978.USD","IE00BKDWB100.SGD","IE00B42XCP33.USD","LU0058720904.USD","LU0868494617.USD","SG9999015341.SGD","LU1974910355.USD","LU2129689431.USD","SG9999018857.SGD","BK7511","LU0211328371.USD","LU2552382058.USD","LU0345769631.USD","SGXZ51526630.SGD","LU0256863811.USD","LU0980610538.SGD","LU0323591593.USD","LU1585245621.USD","LU0661504455.SGD","LU1221951046.USD","LU0114720955.EUR","LU2417539215.USD","IE00B894F039.SGD","BK4585","LU2471134796.USD","LU2133065610.SGD","LU0432979614.USD","LU0265550359.USD","IE00B19Z3581.USD","SG9999015986.USD","LU0354030438.USD","LU2360106947.USD","LU0053666078.USD","LU1069344957.HKD","LU2089984988.USD","LU1989771016.USD","LU1868837136.USD","IE0001KFT4U8.USD","LU0689472784.USD","LU2168564065.EUR","LU0225283273.USD","IE0034235303.USD","LU2505996509.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939006","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658939006?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:50","pubTimestamp":1786366208,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Dianthus Therapeutic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMY","HIYY","HEAL","HMYY","IBRN","BK4196","HIMS","BK4139","HIMZ","DNTH","GLAM","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658239935","title":"Analysts Offer Insights on Consumer Goods Companies: Kenvue, Inc. (KVUE) and Turning Point Brands (TPB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658239935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658239935?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:01","pubTimestamp":1786363274,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Kenvue, Inc. (KVUE) and Turning Point Brands (TPB). Kenvue, I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-kenvue-inc-kvue-and-turning-point-brands-tpb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-kenvue-inc-kvue-and-turning-point-brands-tpb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TPB","LU0708994859.HKD","BK4585","LU0792757196.USD","LU1267930813.SGD","IE00BFXG1179.USD","LU0029864427.USD","LU0889566641.SGD","BK4588","LU1267930573.SGD","RSPS","BK4183","IE00B3T34201.USD","BK4075","KVUE","LU0128525929.USD","LU0310800379.SGD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938940","title":"Apogee Net Loss Widens to $85.85 Million in Q2 FY26; R&D Expenses Rise to $67.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938940","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938940?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:06","pubTimestamp":1786359994,"startTime":"0","endTime":"0","summary":"Apogee net loss widens to $85.85 million in Q2 FY26; R&D expenses rise to $67.3 millionApogee Therapeutics posted a Q2 2026 net loss of $85.85 million, widening from $66.1 million a year earlier.R&D e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLsYr5J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","IE00BLSP4452.SGD","LU2237443465.HKD","IE00BVYPNV92.GBP","IXJ","LU0211328371.USD","TRUH","BCDF","FHLC","BK4533","IE00BJJMRZ35.SGD","JDOC","LU0942090050.USD","LU0069063385.USD","SBIO","LU0985320562.USD","PPH","XLV","LU0289739699.SGD","LU1291159041.SGD","LU2125909247.SGD","LU2095319765.USD","GLAM","LU2089283258.USD","IE000MB6IJN5.SGD","LU2468319806.SGD","NDAQ","IE0002270589.USD","ABBV","LU0912757837.SGD","IE00BJT1NW94.SGD","BK4581","IE00BLSP4239.USD","LU0965508806.USD","LU1732800096.USD","MEDX","RXL","LU1037948897.HKD","IE00B3PB1722.GBP","BK4559","IE0009355771.USD","VHT","APGE","PJP","LU2023251221.USD","LU2433249047.HKD","AGNG","IYH","SG9999014013.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980780","title":"Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980780","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980780?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:58","pubTimestamp":1786359487,"startTime":"0","endTime":"0","summary":"HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding list. Stock rose 6.5% on Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61068991/hims-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIYY","HEAL","HIMY","HIMZ","HMYY","GLAM","HIMS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658732679","title":"Did Align’s Expanded 2026 Buyback and Board Refresh Just Shift Align Technology's (ALGN) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658732679","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658732679?lang=en_us&edition=fundamental","pubTime":"2026-08-09 11:49","pubTimestamp":1786247381,"startTime":"0","endTime":"0","summary":"In late July 2026, Align Technology reported second-quarter 2026 results showing sales rising to US$1,056.19 million year-on-year, issued softer sequential revenue guidance for the third quarter, and outlined the impact of one-time restructuring, depreciation, and legal charges on its GAAP operating margin outlook.\nAt the same time, after discussions with Elliott Investment Management, Align committed to appoint three new independent directors, launched a comprehensive strategic and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/24568-main-header/1590545426137","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24568-main-header/1590545426137"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-algn/align-technology/news/did-aligns-expanded-2026-buyback-and-board-refresh-just-shif","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-algn/align-technology/news/did-aligns-expanded-2026-buyback-and-board-refresh-just-shif","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4534","GLAM","BK4198","LU1974910355.USD","LU2106854487.HKD","BK4504","LU2023250843.SGD","LU1917777945.USD","LU2023250504.SGD","ALGN","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658676186","title":"Hims & Hers Q2 Earnings Preview: Options Traders Brace for a 14.5% Move in HIMS Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2658676186","media":"TIPRANKS","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658676186?lang=en_us&edition=fundamental","pubTime":"2026-08-09 07:19","pubTimestamp":1786231179,"startTime":"0","endTime":"0","summary":"Telehealth platform Hims & Hers Health ($HIMS) will announce its second-quarter results on August 10. HIMS stock rose 6.5% to close at $31.59 on Fr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/hims-hers-q2-earnings-preview-options-traders-brace-for-a-14-5-move-in-hims-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/hims-hers-q2-earnings-preview-options-traders-brace-for-a-14-5-move-in-hims-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMY","HMYY","HIMZ","HIMS","GLAM","BK4196","HEAL","THNR","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657734628","title":"Polymarket Odds: Will RKLB, HIMS, QUBT Beat Earnings on Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2657734628","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657734628?lang=en_us&edition=fundamental","pubTime":"2026-08-08 01:47","pubTimestamp":1786124865,"startTime":"0","endTime":"0","summary":"On Monday, August 10, Rocket Lab ($RKLB), Hims & Hers ($HIMS), and Quantum Computing ($QUBT) will release their earnings. All three companies will ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/polymarket-odds-will-rklb-hims-qubt-beat-earnings-on-monday?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/polymarket-odds-will-rklb-hims-qubt-beat-earnings-on-monday?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HEAL","GLAM","RKLX","BK4170","RKLB","BK4196","FSPC","CQTM","HIMZ","QUBT","BK4187","HIYY","BK4602","QTUP","RKLZ","BK4023","BK4615","BK4585","QUBX","BK4564","HIMY","DIPR","BK4608","HIMS","THNR","BK4591","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657764012","title":"AbbVie Targets Obesity Market With New Phase 2 ABBV-295 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2657764012","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657764012?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:31","pubTimestamp":1786120278,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has launched a Phase 2 dose‑finding study titled “A Phase 2 Dose-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-obesity-market-with-new-phase-2-abbv-295-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-obesity-market-with-new-phase-2-abbv-295-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1732800096.USD","LU1989771016.USD","LU0965509101.SGD","JDOC","LU0820561909.HKD","VHT","LU1093756168.USD","LU1037948897.HKD","IE00B19Z3B42.SGD","FHLC","LU1989772923.USD","IE00BVYPNV92.GBP","LU1430594728.SGD","LU2237443382.USD","BK4550","LU0545039389.USD","IE00BSNM7G36.USD","AGNG","IE000F7OJYX1.SGD","RXL","LU0128525929.USD","LU1244550221.USD","GLAM","PPH","LU0289739699.SGD","LU0256863811.USD","LU1934455863.HKD","LU1983299246.USD","IYH","LU1670628061.USD","MEDX","LU2433249047.HKD","LU1267930573.SGD","LU0868494617.USD","LU0965509010.AUD","LU1267930490.SGD","XLV","LU0943347566.SGD","PJP","LU0058720904.USD","LU1934455277.USD","LU2089283258.USD","BK4566","LU0965508806.USD","SG9999015978.USD","FTXH","IXJ","TRUH","IE00B3PB1722.GBP","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657617822","title":"Spectrum Brands Q3 Sales Beat on Home, Garden Segment Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657617822","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657617822?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:40","pubTimestamp":1786099254,"startTime":"0","endTime":"0","summary":"Spectrum Brands Q3 sales beat on home, garden segment growthOverviewU.S. home essentials supplier's fiscal Q3 net sales rose 7.7%, beating analyst expectationsAdjusted EBITDA more than doubled, aided ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL1N4440BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0792757196.USD","LU0708994859.HKD","LU0029864427.USD","LU1267930573.SGD","BK4588","LU0310800379.SGD","KVUE","LU1267930813.SGD","BK4183","CENT","IE00BFXG1179.USD","LU2065732104.USD","RSPS","GLAM","BK4180","LU0128525929.USD","BK4585","IE00B3T34201.USD","LU0889566641.SGD","BK4018","SPB","LCUT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}